Week In Review This was the week biological-age clocks stopped being a side measurement and became the result itself. Three separate reports — from a pharmaceutical company, an academic sleep lab, and a small-cap gene therapy firm — used clock readouts as the headline endpoint rather than as supporting color. Insilico Medicine
Week In Review The research that landed this week shares an unusual amount of common ground. Almost none of it asks whether an AI system can perform a task — that question is largely settled for the domains under study. It asks instead what condition the human is left in afterward:
Week In Review Four frontier models shipped in seventy-two hours, and the striking thing is not the benchmark leapfrogging but what all four did with access. Anthropic released Claude Fable 5.1 and Claude Mythos 5.1 on September 1 as the same underlying model wearing two different sets of
Week In Review The week’s largest robotics story did not involve a robot. NVIDIA’s agreement to buy Hugging Face for roughly $12.9 billion (NVIDIA to Acquire Hugging Face) is a bet on the distribution layer beneath physical AI — the repository where robot foundation models, datasets, and training
Week In Review Two events this week put instruments where they need to be. On Sunday morning a Falcon Heavy carried the Nancy Grace Roman Space Telescope off Launch Complex 39A, as reported in NASA’s Dark Universe-Seeking Nancy Grace Roman Space Telescope Launches; three days later, 63 million kilometers
Week In Review This was the week fusion stopped being purely a physics story and started behaving like an industry with paperwork. Tennessee’s environmental regulator issued the first commercial fusion machine operating license granted under a fusion-specific state framework, clearing Type One Energy to build a stellarator on a
Week In Review This was a week about industrializing the search for interventions — and about being honest regarding what the search has and has not found. The most consequential paper was an infrastructure paper: A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions describes a single pipeline that
Week In Review This was a week in which aging research kept circling back to a single idea: that much of what we call aging is the immune system responding, sensibly but destructively, to damage it can no longer contain. Two independent papers converged on the same molecular tripwire. In
Week In Review This was a week about plumbing rather than spectacle. The most consequential neurotechnology news was a regulatory letter, not a demo: the FDA told Paradromics it may let trial participants connect an investigational brain implant to their own laptops, tablets, and phones, rather than to company-supplied hardware
Week In Review The week’s defining thread was autonomy pointed in two directions at once. Anthropic published evidence that automated researchers can reliably mitigate alignment failures — Claude agents independently discovering training methods that beat what experienced human safety researchers proposed. Two days earlier, OpenAI published its own accounting of
Week In Review The dominant story of the past week was not a new robot but a new economics. Three separate announcements — XPeng’s robotics unit raising more than $900 million, Gatik’s $200 million Series D, and Bedrock Robotics putting operator-free excavators onto paying job sites — describe an industry
Week In Review The week’s dominant thread was instrumentation — the machinery that turns questions into measurements. It closed with NASA and SpaceX clearing the Nancy Grace Roman Space Telescope for flight in NASA’s Roman Space Telescope ‘Go’ for Launch, an observatory built to survey wide swaths of sky